Form 4 Tracker
Atea Pharmaceuticals, Inc.
AVIR

17 insider filings · Latest: Jun 18, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 18, 2026May 21 10:30 PMPolly A. MurphyDirector
Purchase
6,100$4.17$25.4K92,145(D)

View →

May 18, 2025May 20 8:15 PMPolly A. MurphyDirector
Purchase
6,100$4.17$25.4K92,145(D)

View →

Dec 10, 2024Dec 10 10:17 PMFranklin Berger
Proposed Sale
359,606$2.85$1.0M

View →

Sep 19, 2024Sep 19 8:22 PMJPM Partners LLC
Proposed Sale
1,841$4.00$7.4K

View →

Sep 18, 2024Sep 18 8:09 PMJPM Partners LLC
Proposed Sale
22,187$4.03$89.5K

View →

Sep 17, 2024Sep 17 8:16 PMJPM Partners LLC
Proposed Sale
33,941$4.05$137.3K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 31, 2026Feb 4 12:46 AMJanet MJ HammondChief Development Officer
Option Exercise
58,0500(D)

View →

Jan 31, 2026Feb 4 12:46 AMAndrea CorcoranChief Financial Officer, Executive Vice President, Legal and Secretary
Option Exercise
54,8660(D)

View →

Jan 31, 2026Feb 4 12:46 AMAndrea CorcoranChief Financial Officer, Executive Vice President, Legal and Secretary
Grant/Award
180,000$4.24180,000(D)

View →

Feb 3, 2026Feb 4 12:46 AMSommadossi Jean-PierreDirector, President, CEO, and Chairman
Option Exercise
300,000$1.240(D)

View →

Jan 31, 2026Feb 4 12:46 AMSommadossi Jean-PierreDirector, President, CEO, and Chairman
Option Exercise
272,9830(D)

View →

Jan 31, 2026Feb 4 12:42 AMWayne FosterEVP, Chief Accounting Officer
Option Exercise
41,3330(D)

View →

Jan 31, 2026Feb 4 12:42 AMWayne FosterEVP, Chief Accounting Officer
Grant/Award
108,000$4.24108,000(D)

View →

← Previous

Page 2 of 2